Skin complications of HIV infection
暂无分享,去创建一个
[1] Elizabeth J Horn,et al. A series of critically challenging case scenarios in moderate to severe psoriasis: a Delphi consensus approach. , 2009, Journal of the American Academy of Dermatology.
[2] C. Borrás,et al. Adverse cutaneous reactions associated with the newest antiretroviral drugs in patients with human immunodeficiency virus infection. , 2008, The Journal of antimicrobial chemotherapy.
[3] G. Chêne,et al. Evolving epidemiology of malignancies in HIV , 2008, Current opinion in oncology.
[4] L. Lynen,et al. Prevention and treatment of the immune reconstitution inflammatory syndrome , 2008, Current opinion in HIV and AIDS.
[5] Scott Rose,et al. Effect of aciclovir on HIV-1 acquisition in herpes simplex virus 2 seropositive women and men who have sex with men: a randomised, double-blind, placebo-controlled trial , 2008, The Lancet.
[6] R. Brodell,et al. The treatment of herpes simplex infections: an evidence-based review. , 2008, Archives of internal medicine.
[7] S. Tyring,et al. Double-blind study comparing 2 dosages of valacyclovir hydrochloride for the treatment of uncomplicated herpes zoster in immunocompromised patients 18 years of age and older. , 2008, The Journal of infectious diseases.
[8] S. Tyring,et al. Family history as a risk factor for herpes zoster: a case-control study. , 2008, Archives of dermatology.
[9] R. Aly,et al. The prevalence of dermatophyte infection in patients infected with human immunodeficiency virus , 2008, International journal of dermatology.
[10] Mahnaz Fatahzadeh,et al. Human herpes simplex virus infections: epidemiology, pathogenesis, symptomatology, diagnosis, and management. , 2007, Journal of the American Academy of Dermatology.
[11] A. Gewirtzman,et al. Dermatological management of human immunodeficiency virus (HIV). , 2007, Skin therapy letter.
[12] S. Tyring,et al. Managing herpes zoster in immunocompromised patients. , 2007, Herpes : the journal of the IHMF.
[13] D. Rosmarin,et al. Toxic epidermal necrolysis. , 2007, Journal of the American Academy of Dermatology.
[14] M. Glesby,et al. Dermatologic Adverse Effects of Antiretroviral Therapy , 2007, American journal of clinical dermatology.
[15] C. Martins. Cutaneous drug reactions associated with newer antiretroviral agents. , 2006, Journal of drugs in dermatology : JDD.
[16] R. Watanabe,et al. Treatment of HIV‐associated eosinophilic pustular folliculitis with narrow‐band UVB , 2006, International journal of dermatology.
[17] G. Meintjes,et al. Dermatologic manifestations of the immune reconstitution inflammatory syndrome. , 2006, Dermatologic clinics.
[18] Molly T Hogan. Cutaneous infections associated with HIV/AIDS. , 2006, Dermatologic clinics.
[19] S. Eisman. Pruritic papular eruption in HIV. , 2006, Dermatologic clinics.
[20] R. Schwartz,et al. Eosinophilic pustular folliculitis: a 40 year retrospect. , 2006, Journal of the American Academy of Dermatology.
[21] R. Nguyen,et al. Cutaneous manifestations of HIV in the era of highly active antiretroviral therapy: an institutional urban clinic experience. , 2006, Journal of the American Academy of Dermatology.
[22] D. Raoult,et al. Bartonella quintana Characteristics and Clinical Management , 2006, Emerging infectious diseases.
[23] S. Shelburne,et al. Immune reconstitution inflammatory syndrome: more answers, more questions. , 2006, The Journal of antimicrobial chemotherapy.
[24] P. Easterbrook,et al. Incidence and risk factors for immune reconstitution inflammatory syndrome in an ethnically diverse HIV type 1-infected cohort. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[25] Richard J Hayes,et al. Herpes simplex virus 2 infection increases HIV acquisition in men and women: systematic review and meta-analysis of longitudinal studies , 2006, AIDS.
[26] C. McCall,et al. Eosinophilic Folliculitis in HIV-Infected Women , 2006 .
[27] J. Saurat,et al. Topical tacrolimus for effective treatment of eosinophilic folliculitis associated with human immunodeficiency virus infection. , 2005, Archives of dermatology.
[28] T. Maurer,et al. Eosinophilic folliculitis: before and after the introduction of antiretroviral therapy. , 2005, Archives of dermatology.
[29] S. Tyring,et al. Advances in antiviral therapy. , 2005, Dermatologic clinics.
[30] J. Perfect,et al. Evaluation and management of Fungal infections in Immunocompromised patients , 2005, Dermatologic therapy.
[31] H. Kong,et al. Cutaneous effects of highly active antiretroviral therapy in HIV‐infected patients , 2005, Dermatologic therapy.
[32] A. Katsambas,et al. Cutaneous markers of HIV infection. , 2004, Clinics in dermatology.
[33] M. Levin,et al. Resistance of herpes simplex virus infections to nucleoside analogues in HIV-infected patients. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[34] V. Wiwanitkit. Prevalence of dermatological disorders in Thai HIV‐infected patients correlated with different CD4 lymphocyte count statuses: a note on 120 cases , 2004, International journal of dermatology.
[35] T. Sata,et al. Hair follicle involvement in herpes zoster: pathway of viral spread from ganglia to skin , 1996, Virchows Archiv.
[36] A. Milito. B lymphocyte dysfunctions in HIV infection. , 2004 .
[37] N. Scheinfeld,et al. Eosinophilic Pustular Folliculitis , 2004 .
[38] C. James,et al. Enfuvirtide: A Novel Agent for the Treatment of HIV-1 Infection , 2003, The Annals of pharmacotherapy.
[39] C. Burkhart,et al. Tinea corporis in human immunodeficiency virus‐positive patients: case report and assessment of oral therapy , 2003, International journal of dermatology.
[40] R. Sarisky,et al. Profiling penciclovir susceptibility and prevalence of resistance of herpes simplex virus isolates across eleven clinical trials , 2003, Archives of Virology.
[41] J. Gnann. Varicella-zoster virus: atypical presentations and unusual complications. , 2002, The Journal of infectious diseases.
[42] S. Tyring,et al. Antiviral agents: Nonantiviral drugs , 2002 .
[43] S. Tyring,et al. Verrucous herpes of the scrotum in a human immunodeficiency virus‐positive man: case report and review of the literature , 2002, Journal of the European Academy of Dermatology and Venereology : JEADV.
[44] R. Whitley,et al. Clinical practice. Herpes zoster. , 2002, The New England journal of medicine.
[45] J. Arrese,et al. Skin manifestations of Bartonella infections , 2002, International journal of dermatology.
[46] S. Tyring,et al. The cutaneous manifestations of HIV infection. , 2002, Dermatologic clinics.
[47] T. M. Chen,et al. Clinical manifestations of varicella-zoster virus infection. , 2002, Dermatologic clinics.
[48] T. Horn,et al. The histopathology of folliculitis in HIV‐infected patients , 2002, Journal of cutaneous pathology.
[49] G. Russo,et al. Cutaneous manifestations of antiretroviral therapy. , 2002, Journal of the American Academy of Dermatology.
[50] A. Wald,et al. Risk of human immunodeficiency virus infection in herpes simplex virus type 2-seropositive persons: a meta-analysis. , 2002, The Journal of infectious diseases.
[51] Eduardo Fonseca,et al. Indinavir-Induced Retinoid-Like Effects , 2002, Drug safety.
[52] J. Bingham,et al. Dermatological immune restoration syndrome: does it exist? , 2001, Journal of the European Academy of Dermatology and Venereology : JEADV.
[53] N. Naing,et al. Cutaneous manifestations in HIV positive patients. , 2001, The Southeast Asian journal of tropical medicine and public health.
[54] P. Ljungman,et al. A Randomized, Double-Blind Trial of Famciclovir Versus Acyclovir for the Treatment of Localized Dermatomal Herpes Zoster in Immunocompromised Patients , 2001, Cancer investigation.
[55] M. Rinaldi,et al. Dermatophytosis: Epidemiological and microbiological update , 2000 .
[56] R. Johnson,et al. Dermatophyte infections in human immune deficiency virus (HIV) disease. , 2000, Journal of the American Academy of Dermatology.
[57] S. Tyring,et al. Antiviral therapy for herpes zoster: randomized, controlled clinical trial of valacyclovir and famciclovir therapy in immunocompetent patients 50 years and older. , 2000, Archives of family medicine.
[58] B. Cochener,et al. Comparison of the efficacy and safety of valaciclovir and acyclovir for the treatment of herpes zoster ophthalmicus. , 2000, Ophthalmology.
[59] S. Tyring,et al. Cutaneous viral infections in HIV-infected individuals. , 2000, Clinics in dermatology.
[60] J. Machadob,et al. Bacillary angiomatosis by Bartonella quintana in an HIV-infected patient. , 2000 .
[61] B. Rentier,et al. Chronic verrucous varicella zoster virus skin lesions: clinical, histological, molecular and therapeutic aspects , 1999, Clinical and experimental dermatology.
[62] Rowe,et al. Itchy folliculitis and human immunodeficiency virus infection: clinicopathological and immunological features, pathogenesis and treatment , 1999, The British journal of dermatology.
[63] S. Tyring,et al. Herpes. Atypical clinical manifestations. , 1998, Dermatologic clinics.
[64] D. Raoult,et al. Bacillary angiomatosis in immunocompromised patients , 1998, AIDS.
[65] T. Schacker,et al. Frequent recovery of HIV-1 from genital herpes simplex virus lesions in HIV-1-infected men. , 1998, JAMA.
[66] J. Kaldor,et al. Herpes zoster and the stage and prognosis of HIV-1 infection. , 1997, Genitourinary medicine.
[67] C. Darley,et al. The prevalence of skin disease in HIV infection and its relationship to the degree of immunosuppression , 1997, The British journal of dermatology.
[68] S. Lee,et al. A randomized, double-blind, placebo-controlled trial of cidofovir gel for the treatment of acyclovir-unresponsive mucocutaneous herpes simplex virus infection in patients with AIDS. , 1997, The Journal of infectious diseases.
[69] J. Tappero,et al. Bacillary angiomatosis and other Bartonella species infections. , 1997, Seminars in cutaneous medicine and surgery.
[70] S. Vallurupalli,et al. UVB phototherapy is an effective treatment for pruritus in patients infected with HIV. , 1997, Journal of the American Academy of Dermatology.
[71] B. Elewski,et al. Fungal infections in HIV-infected patients. , 1997, Seminars in cutaneous medicine and surgery.
[72] R. Brettle. Bacterial infections in HIV: the extent and nature of the problem , 1997, International journal of STD & AIDS.
[73] C. Kemper,et al. Bacillary angiomatosis and bacillary peliosis in patients infected with human immunodeficiency virus: clinical characteristics in a case-control study. , 1996, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[74] J. Feldman,et al. Increased Genital Shedding of Herpes Simplex Virus Type 2 in HIV-Seropositive Women , 1995, Annals of Internal Medicine.
[75] K. Beutner,et al. Valacyclovir: a review of its antiviral activity, pharmacokinetic properties, and clinical efficacy. , 1995, Antiviral research.
[76] T. Maurer,et al. Eosinophilic Folliculitis: The Histologic Spectrum , 1995, The American Journal of dermatopathology.
[77] J. V. D. van der Meer,et al. Herpes zoster, immunological deterioration and disease progression in HIV‐1 infection , 1995, AIDS.
[78] C. Otley,et al. Isotretinoin treatment of human immunodeficiency virus-associated eosinophilic folliculitis. Results of an open, pilot trial. , 1995, Archives of dermatology.
[79] R. Chaisson,et al. Clinical spectrum of herpes zoster in adults infected with human immunodeficiency virus. , 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[80] J. Tappero,et al. Cutaneous manifestations of opportunistic infections in patients infected with human immunodeficiency virus. , 1995 .
[81] A. Sivayathorn,et al. Prevalence of skin disease in patients infected with human immunodeficiency virus in Bangkok, Thailand. , 1995, Annals of the Academy of Medicine, Singapore.
[82] D. Friedman,et al. Valaciclovir compared with acyclovir for improved therapy for herpes zoster in immunocompetent adults , 1995, Antimicrobial agents and chemotherapy.
[83] T. Berger,et al. Itraconazole therapy for human immunodeficiency virus-associated eosinophilic folliculitis. , 1995, Archives of dermatology.
[84] R. Stern,et al. Cutaneous disease and drug reactions in HIV infection. , 1993, The New England journal of medicine.
[85] Jennifer Y. Liu,et al. Herpes zoster and human immunodeficiency virus infection. , 1992, The Journal of infectious diseases.
[86] J. Palefsky,et al. Chronic Verrucous Varicella‐Zoster Virus Infection in Patients with the Acquired Immunodeficiency Syndrome (AIDS): Histologic and Molecular Biologic Findings , 1992, The American Journal of dermatopathology.
[87] P. Leboit,et al. Human immunodeficiency virus-associated eosinophilic folliculitis. A unique dermatosis associated with advanced human immunodeficiency virus infection. , 1991, Archives of dermatology.
[88] C. Cockerell,et al. Bacillary angiomatosis: a newly characterized, pseudoneoplastic, infectious, cutaneous vascular disorder. , 1990, Journal of the American Academy of Dermatology.
[89] Timothy G. Berger,et al. Bacillary Angiomatosis: The Histopathology and Differential Diagnosis of a Pseudoneoplastic Infection in Patients with Human Immunodeficiency Virus Disease , 1989, The American journal of surgical pathology.
[90] O. Laskin,et al. Disseminated ecthymatous herpes varicella-zoster virus infection in patients with acquired immunodeficiency syndrome. , 1989, Journal of the American Academy of Dermatology.
[91] R. Schinella,et al. Eosinophilic pustular folliculitis in patients with acquired immunodeficiency syndrome. Report of three cases. , 1986, Journal of the American Academy of Dermatology.
[92] M. Stoler,et al. An atypical subcutaneous infection associated with acquired immune deficiency syndrome. , 1983, American journal of clinical pathology.